These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9416698)

  • 21. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
    Liu JR; Lin Q; Wu XY
    Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
    Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
    Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
    Herbst H; Samol J; Foss HD; Raff T; Niedobitek G
    J Pathol; 1997 Jul; 182(3):299-306. PubMed ID: 9349232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's disease in Costa Rica: a report of 40 cases analyzed for Epstein-Barr virus.
    Monterroso V; Zhou Y; Koo S; Glackin C; Bujan W; Medeiros LJ
    Am J Clin Pathol; 1998 May; 109(5):618-24. PubMed ID: 9576582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection.
    Huh J; Park C; Juhng S; Kim CE; Poppema S; Kim C
    Cancer; 1996 Mar; 77(5):949-55. PubMed ID: 8608489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease.
    Vasef MA; Kamel OW; Chen YY; Medeiros LJ; Weiss LM
    Am J Pathol; 1995 Nov; 147(5):1408-15. PubMed ID: 7485403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese.
    Leung SY; Yuen ST; Chung LP; Chan AS; Wong MP
    Int J Cancer; 1997 Jul; 72(2):225-30. PubMed ID: 9219824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paediatric Hodgkin's disease in Spain: association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections.
    Santón A; Martín C; Manzanal AI; Preciado MV; Bellas C
    Br J Haematol; 1998 Oct; 103(1):129-36. PubMed ID: 9792299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: a pathological and virological study.
    Trimèche M; Bonnet C; Korbi S; Boniver J; de Leval L
    Leuk Lymphoma; 2007 Jul; 48(7):1323-31. PubMed ID: 17613761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Epstein-Barr virus markers in Reed-Sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country.
    Belkaid MI; Brière J; Djebbara Z; Beldjord K; Andrieu JM; Colonna P
    Leuk Lymphoma; 1995 Mar; 17(1-2):163-8. PubMed ID: 7773154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma.
    Knecht H; Bachmann E; Brousset P; Sandvej K; Nadal D; Bachmann F; Odermatt BF; Delsol G; Pallesen G
    Blood; 1993 Nov; 82(10):2937-42. PubMed ID: 8219183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease.
    Brousset P; Schlaifer D; Meggetto F; Bachmann E; Rothenberger S; Pris J; Delsol G; Knecht H
    Blood; 1994 Oct; 84(8):2447-51. PubMed ID: 7919364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease.
    Dolcetti R; Zancai P; De Re V; Gloghini A; Bigoni B; Pivetta B; De Vita S; Carbone A; Boiocchi M
    Blood; 1997 Mar; 89(5):1723-31. PubMed ID: 9057656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.
    Sandvej K; Peh SC; Andresen BS; Pallesen G
    Blood; 1994 Dec; 84(12):4053-60. PubMed ID: 7994023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.